These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16109324)

  • 1. Toward an improved diagnosis of the metabolic syndrome other clues to the presence of insulin resistance.
    Cohn GS; Kittleson MM; Blumenthal RS
    Am J Hypertens; 2005 Aug; 18(8):1099-103. PubMed ID: 16109324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults.
    Can AS; Ozbayrakçi S; Palaoğlu KE; Bersot TP
    J Cardiometab Syndr; 2009; 4(1):26-32. PubMed ID: 19245513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now?
    Sattar N
    Minerva Endocrinol; 2005 Sep; 30(3):121-38. PubMed ID: 16208304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians.
    Pei D; Kuo SW; Wu DA; Lin TY; Hseih MC; Lee CH; Hsu WL; Chen SP; Sheu WH; Li JC
    Int J Clin Pract; 2005 Dec; 59(12):1408-16. PubMed ID: 16351672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy.
    Cordero A; Laclaustra M; León M; Grima A; Casasnovas JA; Luengo E; del Rio A; Ferreira I; Alegria E
    Am J Hypertens; 2006 Feb; 19(2):189-96; discussion 197-8. PubMed ID: 16448891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
    Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
    Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
    Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk.
    Smith SR
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():128S-134S. PubMed ID: 16931494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic criteria of insulin resistance and multiple risk factor syndrome].
    Hashimoto N; Saito Y
    Nihon Rinsho; 2000 Feb; 58(2):405-10. PubMed ID: 10707566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38).
    Mohan V; Sandeep S; Deepa M; Gokulakrishnan K; Datta M; Deepa R
    Diabetes Obes Metab; 2007 May; 9(3):337-43. PubMed ID: 17391160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.